WANBURY share price has zoomed 7% and is presently trading at Rs 256.0.
Meanwhile, the BSE HEALTHCARE index is at 44,692.9 (down 0.2%).
Among the top gainers in the BSE HEALTHCARE index today are POLY MEDICURE (up 3.1%) and COHANCE LIFESCIENCES (up 1.5%).
Natco Pharma (down 5.0%) and Abbott India (down 1.8%) are among the top losers today.
Over the last one year, WANBURY has moved up from Rs 223.1 to Rs 256.0, registering a gain of Rs 32.9 (up 14.7%).
On the other hand, the BSE HEALTHCARE index has moved up from 43,384.9 to 44,692.9, registering a gain of 3.0% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were LAURUS LABS (up 87.7%), NARAYANA HRUDAYALAYA (up 55.4%) and ASTER DM HEALTHCARE (up 52.0%).
Must See: Should You Sell? Hold? Or Buy the Dip?
The BSE Sensex is at 85,635.4 .
The top gainers among the BSE Sensex today are Bajaj Finance (up 2.1%) and ICICI Bank (up 1.2%). The most traded stocks in the BSE Sensex are HDFC Bank and SBI.
In the meantime, NSE Nifty is at 26,177.9 (down 0.1%). Eicher Motor and Adani Enterprises are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 80,109.9 to 85,635.4, registering a gain of 5,525.5 points (up 6.9%).
WANBURY net profit grew 89.3% YoY to Rs 152 million for the quarter ended September 2025, compared to a profit of Rs 80 million a year ago. Net sales declined 0.7% to Rs 1,601 million during the period as against Rs 1,612 million in July-September 2024.
For the year ended March 2025, WANBURY reported 45.4% decrease in net profit to Rs 305 million compared to net profit of Rs 560 million during FY24. Revenue of the company grew 3.8% to Rs 5,995 million during FY25.
The current Price to earnings ratio of WANBURY, based on rolling 12 month earnings, stands at 17.8.
Image source: Eoneren/www.istockphoto.com
Equitymaster requests your view! Post a comment on "WANBURY Gains 7%; BSE HEALTHCARE Index Down 0.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!